DEF: Royce Global Trust Sets Annual Meeting for Director Election

Royce Global Trust, Inc. announced its Annual Meeting of Stockholders on October 8, 2025, to elect two Class II Directors and address other business.

Summary

• The Annual Meeting of Stockholders will be held on Wednesday, October 8, 2025, at 2:30 p.m. (Eastern Time) at the Fund's offices in New York.
• The primary purpose of the meeting is to elect two Class II Directors, Patricia W. Chadwick and Michael K. Shields, for a three-year term expiring at the Fund's 2028 Annual Meeting.
• The record date for determining stockholders entitled to vote is August 5, 2025.
• The Board of Directors consists of seven Directors, divided into three classes with three-year terms, with six of the seven Directors being Independent Directors.
• Christopher C. Grisanti has been designated as the lead Independent Director.
• An ongoing legal proceeding challenges the Fund's opt-in to the Maryland Control Share Acquisition Act (MCSAA), which was declared in violation of the Investment Company Act by a District Court and affirmed by the Second Circuit; the U.S. Supreme Court granted certiorari on June 30, 2025, to resolve a circuit split on implied rights of action.
• As of the record date, there were 6,519,010 shares of Common Stock outstanding.
• Significant beneficial owners include Cede & Co. (98.08%), Charles M. Royce (16.21%), Raymond James & Associates (8.5% as of March 31, 2025), and Morgan Stanley (6.50% as of June 30, 2025).
• Directors and officers, as a group, beneficially owned approximately 1.35% of the Fund's outstanding shares of Common Stock as of the record date.
• Audit fees paid to PricewaterhouseCoopers LLP (PWC) were $24,837 for the fiscal year ended December 31, 2024, and $24,113 for 2023.
• Tax fees paid to PWC were $11,189 for 2024 and $10,863 for 2023.
• Independent Directors received an annual rate of $2,500 for Board service plus $250 per Board meeting attended for 2024 and 2025.

Sentiment

Score: 5

Explanation: The filing is a standard proxy statement for an annual meeting, primarily procedural. The ongoing legal challenge regarding the MCSAA introduces a degree of uncertainty, but it's a known issue being addressed at the highest court level, not a new negative development. No significant positive or negative financial or operational news is disclosed.

Positives

• The Board structure includes a strong majority of Independent Directors (6 out of 7), exceeding regulatory requirements and promoting robust oversight.
• Two Audit Committee Financial Experts, Patricia W. Chadwick and Julia W. Poston, are designated, enhancing financial oversight capabilities.
• A comprehensive corporate governance framework is in place, with established Audit and Nominating Committees and clearly defined charters.
• The Board conducts an annual performance evaluation, indicating a commitment to continuous improvement in governance.
• Directors and officers hold shares in the Fund, aligning their interests with those of the stockholders.

Negatives

• An ongoing legal proceeding regarding the Maryland Control Share Acquisition Act (MCSAA) opt-in has resulted in adverse rulings at lower courts, with the case now before the U.S. Supreme Court, creating uncertainty regarding corporate control provisions.
• The Nominating Committee did not hold any meetings during the year ended December 31, 2024, which could suggest less active engagement in director candidate identification or review during that period.
• Only one Director attended the Fund's 2024 Annual Meeting of Stockholders, potentially indicating low direct engagement with shareholders at such events.

Risks

• Legal risk: The ongoing litigation concerning the Maryland Control Share Acquisition Act (MCSAA) and its potential implications on corporate governance and shareholder rights, specifically the Supreme Court's review of whether private parties have an implied right of action to enforce certain provisions of the Investment Company Act of 1940.
• Governance risk: The MCSAA litigation could impact the Fund's ability to implement certain defensive measures against hostile takeovers or control acquisitions, potentially altering the balance of power between management and activist shareholders.

Future Outlook

The filing primarily focuses on the upcoming annual meeting and corporate governance matters. It notes that the Semiannual Report for the six-month period ended June 30, 2025, will be made available in late August 2025, which will contain updated financial information. The ongoing Supreme Court case regarding the Investment Company Act of 1940 could have significant future implications for corporate governance practices and shareholder rights within the investment company industry.

Management Comments

• The Board of Directors of the Fund recommends that all stockholders vote FOR all of the Director nominees.

Industry Context

This proxy statement is a routine disclosure for a U.S. investment company, detailing corporate governance, director elections, and audit information. The most significant industry context is the ongoing legal challenge to the Maryland Control Share Acquisition Act (MCSAA) opt-in, which is a critical issue for closed-end funds. The Supreme Court's decision on whether private parties have an implied right of action to enforce certain provisions of the Investment Company Act of 1940 will set a major precedent, potentially impacting corporate governance, anti-takeover defenses, and shareholder activism across the entire fund industry.

Comparison to Industry Standards

• The Board's composition, with 6 out of 7 Directors being Independent Directors, exceeds the Investment Company Act requirement of at least 40% and the exemptive rule requirement of a majority, aligning with strong corporate governance practices in the investment fund industry.
• The designation of Patricia W. Chadwick and Julia W. Poston as Audit Committee Financial Experts meets SEC regulations and industry best practices for robust financial oversight within investment companies.
• The ongoing legal challenge regarding the Maryland Control Share Acquisition Act (MCSAA) is a unique and significant deviation from standard anti-takeover provisions, as it has been ruled in violation of the Investment Company Act. This specific litigation (Saba Capital Master Funds., Ltd., et al. v. Clearbridge Energy Midstream Opportunity Fund, Inc., et al.) serves as a key benchmark for similar cases and the interpretation of shareholder rights in the closed-end fund sector.
• The compensation structure for Independent Directors, including a base annual rate and per-meeting fees, is a common practice in the fund industry, though specific amounts would require detailed comparison to peer funds of similar size and complexity to assess competitiveness.

Corporate Governance

Legal Proceedings

• Saba Capital Master Funds., Ltd., et al. v. Clearbridge Energy Midstream Opportunity Fund, Inc., et al., No. 1:23-cv-05568 (S.D.N.Y.): An action filed on June 29, 2023, against the Fund and others, seeking rescission of the defendants' election to opt into the provisions of the Maryland Control Share Acquisition Act (MCSAA).
• On January 4, 2024, the U.S. District Court for the Southern District of New York issued an opinion and order declaring that the control share resolutions (including the MCSAA opt-in) violate a provision of the Investment Company Act and ordered their rescission.
• Following an appeal by the Fund and other remaining defendants, the district court's judgment was affirmed in full by the United States Court of Appeals for the Second Circuit on June 26, 2024.
• On or about September 24, 2024, the Fund and certain defendants filed a petition with the U.S. Supreme Court for a writ of certiorari to review the June 26, 2024, judgment of the Second Circuit.
• On June 30, 2025, the Supreme Court granted certiorari, agreeing to resolve a circuit split over whether private parties have an implied right of action to enforce certain provisions of the Investment Company Act of 1940.

Related Party Transactions

• Royce & Associates, LP serves as the Fund's investment adviser, and its officers and employees may solicit proxies for the Annual Meeting.
• Christopher D. Clark, President and a Director of the Fund, is an interested person due to his executive positions with Royce & Associates, LP.
• Charles M. Royce, a Senior Adviser to Royce, beneficially owns 16.21% of the Fund's outstanding shares.
• PricewaterhouseCoopers LLP (PWC) billed non-audit fees of $11,189 in 2024 and $10,863 in 2023 for services rendered to Royce and its affiliates that provide ongoing services to the Fund.

Stakeholder Impact

• Shareholders: Will participate in the election of Directors and are directly impacted by the ongoing legal proceedings concerning the Maryland Control Share Acquisition Act (MCSAA), which could affect their voting rights and corporate control mechanisms. The Supreme Court's decision will clarify the enforceability of certain provisions under the Investment Company Act.
• Management and Board of Directors: The Board's composition and governance structure are being affirmed through the election process. The legal proceeding presents a significant challenge to existing corporate governance practices and requires ongoing attention from management and the Board.
• Investment Adviser (Royce & Associates, LP): Continues its role as the Fund's investment adviser, with its officers also serving in key roles within the Fund, maintaining operational continuity and strategic direction.
• Auditors (PricewaterhouseCoopers LLP): Continue to provide audit and tax services, with their independence and fees subject to Audit Committee oversight.

Next Steps

• Stockholders are encouraged to vote on Director nominees by October 7, 2025, 11:59 PM ET, via internet or telephone, or by returning the proxy card by mail.
• The Annual Meeting of Stockholders will be held on October 8, 2025.
• The Semiannual Report to Stockholders for the six-month period ended June 30, 2025, will be made available in late August 2025.
• The U.S. Supreme Court will resolve a circuit split over whether private parties have an implied right of action to enforce certain provisions of the Investment Company Act of 1940.
• Stockholder proposals intended for inclusion in the Fund's 2026 Annual Meeting Proxy Statement must be received by April 17, 2026.
• Advance notice for stockholder nominations or other business for the 2026 Annual Meeting must be received between March 25, 2026, and April 24, 2026.

Key Dates

Recommendation

This filing is a standard proxy statement for an annual meeting, primarily focused on corporate governance and director elections. It does not contain new financial performance data or strategic shifts that would warrant a change in investment recommendation. The ongoing legal challenge regarding the Maryland Control Share Acquisition Act is a known, previously disclosed issue that is now before the Supreme Court, and its resolution will be a key factor to monitor, but it doesn't present an immediate catalyst for a 'buy' or 'sell' decision based solely on this procedural filing. Investors should hold and monitor the outcome of the legal proceedings and future financial reports.

Keywords

Royce Global Trust, SEC filing, proxy statement, annual meeting, director election, corporate governance, investment company, shareholder vote, legal proceedings, Maryland Control Share Acquisition Act, Investment Company Act of 1940, audit committee, nominating committee, financial reporting, fund management, Royce Investment Partners